Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa
Authors
Keywords
-
Journal
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 27, Issue 3, Pages 251-253
Publisher
Informa UK Limited
Online
2015-10-20
DOI
10.3109/09546634.2015.1094179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New onset of articular inflammatory manifestations in patients with hidradenitis suppurativa under treatment with infliximab
- (2015) Emilie Acquacalda et al. JOINT BONE SPINE
- PsAPASH: A new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition
- (2015) Rosita Saraceno et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
- (2015) C.C. Zouboulis et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Successful Treatment of Hidradenitis Suppurativa with Infliximab in a Patient Who Failed to Respond to Etanercept
- (2015) Yves Poulin JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Hidradenitis Suppurativa Associated with Spondyloarthritis -- Results from a Multicenter National Prospective Study
- (2014) P. Richette et al. JOURNAL OF RHEUMATOLOGY
- Use of biological treatments in patients with hidradenitis suppurativa
- (2014) G. Martin-Ezquerra et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
- (2013) Alexa B. Kimball et al. ANNALS OF INTERNAL MEDICINE
- Hidradenitis suppurrativa (acne inversa) as a systemic disease
- (2013) Clio Dessinioti et al. CLINICS IN DERMATOLOGY
- Paradoxical effects of anti-TNF-α agents in inflammatory diseases
- (2013) Daniel Wendling et al. Expert Review of Clinical Immunology
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- (2013) Cornelia Tillack et al. GUT
- Systematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseases
- (2013) Laurent Machet et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists
- (2012) Elena B. Hawryluk et al. JOURNAL OF CUTANEOUS PATHOLOGY
- A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
- (2011) I. Miller et al. BRITISH JOURNAL OF DERMATOLOGY
- A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa
- (2010) Masahiro Amano et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study
- (2009) H.H. van der Zee et al. BRITISH JOURNAL OF DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More